DocGo Inc. Payments of Ordinary Dividends, Noncontrolling Interest
DocGo Inc. (DCGO) reported Payments of Ordinary Dividends, Noncontrolling Interest of $1.02 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsMinorityInterest · last filed 2026-08-17
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2026-06-30 was $0.00.
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2026-03-31 was $1.02M.
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for the quarter ending 2025-09-30 was $175.83K.
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2025 was $175.83K, a 86.42% decline from fiscal 2024.
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2024 was $1.29M.
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2023 was $0.00.
- DocGo Inc. payments of ordinary dividends, noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Payments of Ordinary Dividends, Noncontrolling Interest 3 month | Payments of Ordinary Dividends, Noncontrolling Interest 6 month | Payments of Ordinary Dividends, Noncontrolling Interest 9 month | Payments of Ordinary Dividends, Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $1.02M 10-Q · filed 2026-08-17 | $1.02M derived: sum of 3 quarters · filed 2026-08-17 | $1.20M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | $1.02M 10-Q · filed 2026-05-11 | $1.02M derived: sum of 2 quarters · filed 2026-05-11 | $1.20M derived: sum of 3 quarters · filed 2026-05-11 | $1.20M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $175.83K derived: sum of 2 quarters · filed 2026-03-16 | $175.83K derived: sum of 3 quarters · filed 2026-08-17 | $175.83K 10-K · filed 2026-03-16 |
| 2025-09-30 | $175.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $175.83K derived: sum of 2 quarters · filed 2026-08-17 | $175.83K 10-Q · filed 2025-11-10 | $1.22M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-17 | $0.00 10-Q · filed 2026-08-17 | $1.04M derived: sum of 3 quarters · filed 2026-08-17 | $1.04M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-11 | $1.04M derived: sum of 2 quarters · filed 2026-05-11 | $1.04M derived: sum of 3 quarters · filed 2026-05-11 | |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.04M derived: sum of 2 quarters · filed 2026-03-16 | $1.29M 10-K · filed 2026-03-16 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $250.00K 10-Q · filed 2025-11-10 | ||
| 2024-06-30 | $250.00K 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $0.00 derived: sum of 2 quarters · filed 2026-03-16 | $0.00 10-K · filed 2026-03-16 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-07 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |